drugset / Trial / NCT00667745

Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder

NCT00667745

Phase 4 Completed 283 enrolled National Institute of Mental Health (NIMH)
RandomizedParallel-groupSingle-blindTreatment

Summary

This study evaluated whether lithium included as part of optimized medication treatment improved overall level of illness, symptoms of mania and depression, and quality of life in people with bipolar disorder.

Timeline

Start
2008-04
Primary completion
2010-03
Completion
2010-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Carbonate Unknown 600 mg

Indications